VF
TEVA icon

Virtu Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Virtu Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,601
Closed -$865K – 2079
2025
Q2 		$865K Buy
51,601
+27,447
+114% +$443K 0.04% 387
2025
Q1 		$371K Buy
+24,154
New +$431K 0.02% 592
2023
Q2 		– Sell
-59,842
Closed -$530K – 2033
2023
Q1 		$530K Buy
+59,842
New +$592K 0.06% 327
2022
Q4 		– Sell
-117,906
Closed -$951K – 2123
2022
Q3 		$951K Sell
117,906
-193,682
-62% -$1.71M 0.09% 209
2022
Q2 		$2.34M Buy
+311,588
New +$2.71M 0.2% 83
2022
Q1 		– Sell
-160,971
Closed -$1.29M – 2020
2021
Q4 		$1.29M Buy
+160,971
New +$1.45M 0.13% 149
2020
Q4 		– Sell
-18,242
Closed -$164K – 1787
2020
Q3 		$164K Sell
18,242
-5,834
-24% -$61.7K 0.03% 629
2020
Q2 		$297K Buy
+24,076
New +$272K 0.03% 557
2019
Q4 		$3.72M Buy
380,072
+170,752
+82% +$1.52M 0.36% 44
2019
Q3 		$1.44M Buy
209,320
+156,871
+299% +$1.2M 0.11% 188
2019
Q2 		$484K Sell
52,449
-23,231
-31% -$280K 0.03% 543
2019
Q1 		$1.19M Sell
75,680
-19,763
-21% -$349K 0.07% 269
2018
Q4 		$1.47M Sell
95,443
-176,094
-65% -$3.61M 0.08% 189
2018
Q3 		$5.85M Buy
271,537
+236,044
+665% +$5.48M 0.36% 36
2018
Q2 		$863K Buy
35,493
+10,948
+45% +$223K 0.05% 480
2018
Q1 		$419K Buy
+24,545
New +$479K 0.02% 809
2017
Q4 		– Sell
-66,168
Closed -$1.17M – 2996
2017
Q3 		$1.17M Buy
+66,168
New +$1.49M 0.06% 380
2017
Q2 		– Sell
-6,225
Closed -$200K – 514
2017
Q1 		$200K Buy
+6,225
New +$212K 0.02% 364

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Virtu Financial's TEVA Position: Q3 2025 in Review

Virtu Financial sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 51,601 shares — an estimated $865K sold.

Virtu Financial first reported a position in TEVA in Q1 2017 and held it in 18 quarters. The position peaked at $5.85M in Q3 2018. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Virtu Financial reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 51,601 Teva Pharmaceuticals shares in Q3 2025, an estimated $865K.
  • Virtu Financial first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 18 quarters.
  • Virtu Financial's Teva Pharmaceuticals position peaked at $5.85M in Q3 2018.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.